ResApp revamps clinical trial of smartphone app to diagnose respiratory disease
CEO Tony Keating shared some of the lessons learned from the first trial in a Skype interview from Sydney, Australia.
CEO Tony Keating shared some of the lessons learned from the first trial in a Skype interview from Sydney, Australia.
ResApp has developed a smartphone app that uses audio samples of a patient's cough to diagnose acute respiratory diseases. A U.S. pediatric study will assess how the app stacks up against respiratory tests conducted by hospitals to diagnose patients.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
For illnesses, such as pneumonia, each person creates a unique sound signature when they cough. Based on four to five coughs, signal-processing algorithms in this app can detect those patterns, identifying both the type and severity of an ailment.